Session » Pediatric Rheumatology: Clinical and Therapeutic Disease IV: Childhood Therapeutics and Response
-
Abstract Number: 2593
Predictive Markers of Therapeutical Outcome and Their Role in the Ethiopathology of Juvenile Idiopathic Arthritis
-
Abstract Number: 2594
Epigenetic Signature of the Response to Anti-TNF in Juvenile Idiopathic Arthritis
-
Abstract Number: 2595
S100A12 At Baseline May Be Useful for Predicting Inactive Disease within 12 Months in Polyarticular Juvenile Idiopathic Arthritis
-
Abstract Number: 2596
Rituximab Treatment for Antineutrophil Cytoplasmic Antibody – Associated Vasculitis in Children
-
Abstract Number: 2597
Degree of Initial Intracellular Folate Depletion May Predict Methotrexate Response in Juvenile Idiopathic Arthritis
-
Abstract Number: 2598
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure